BioSpace News Archive

The COVID-19 outbreak has increased the number of critically ill patients across the globe. Due to the nature of the virus, the patient is unable to breathe comfortably and hence is kept under ventilators.

Transparency Market Research has published a new report titled, “Life Science Instrumentation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027”.

Transparency Market Research has published a new report titled ‘Custom Procedure Packs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027.’ According to the new report, the global custom procedure packs market was valued above US$ 10,000 Mn in 2018.

In its recent report, Transparency Market Research gives intricate details about the global behavioral health market. In recent years, there has been a considerable rise in the number of cases of mental health disorders.

Seagen Inc. (Nasdaq:SGEN) today announced the presentation of new data from its growing pipeline of marketed and investigational therapies at the virtual scientific program of the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, to be held June 4-8.

Commercial trademark application FILED for CoviDTH® diagnostic cancer vaccine platform patent coverage expanded to NOW include over 12 tumor types

Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone Bio”), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, will release financial results for the first quarter ended March 31, 2021, after market close on Thursday, May 13, 2021 at 4:30 p.m. Eastern time.

Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, today announced that the Company will report its financial results for the three months ended March 31, 2021 on Thursday, May 6, 2021 at 4:30 p.m. (ET).

– Methylmalonic Acidemia ( MMA) program to become wholly-owned by Selecta – – Selecta to postpone IND submission until at least the fourth quarter of 2021 – – Empty capsid (SEL-399) study remains on track –

Highlights: Michael J. Fox Foundation grants Alterity $US495K for Parkinson’s disease research evaluation Strengthening profile at investment, scientific and clinical conferences Dr David Stamler appointed Chief Executive Officer Cash balance as at 31 March 2021 of A$32.8M